Zevtera Injection, Powder, For Solution
Product Images NDC 68547-578

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Zevtera (NDC 68547-578). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by La Jolla Pharmaceutical Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Zevtera 01)

Chemical structure of ceftobiprole medocaril sodium, the active ingredient in ZEVTERA 667 mg injection powder for solution. The diagram shows the molecular arrangement with rings, bonds, and functional groups relevant to the cephalosporin class antibiotic.*

FDA Label Image

Principal Display Panel (667 mg Vial Box)

Packaging label for ZEVTERA 667 mg/vial injection powder, containing ceftobiprole medocaril sodium for intravenous use. The label indicates a carton of 10 single-dose vials, distributed by La Jolla Pharmaceutical Company. It includes usage instructions, storage conditions, and inactive ingredient details, with a prominent blue panel showing the strength and drug name.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.